Santhera Pharmaceuticals Holding Ltd.
SANN
ISIN CH1276028821 / Valor 127602882
Santhera Pharmaceuticals Holding Ltd.
UMushroom community rating:
About company
Santhera Pharmaceuticals Holding Ltd. is a Swiss specialty pharmaceutical company that develops and commercializes therapies for rare neuromuscular, mitochondrial and related pulmonary disorders. Its work has centered on orphan-drug programs — most prominently formulations of idebenone (marketed in some indications) — and clinical development efforts in Duchenne muscular dystrophy and other rare disease indications. The company operates as a typical small-cap biotech, generating revenues from product sales where marketed and from partnerships, milestone and licensing arrangements, while relying on ongoing clinical development, regulatory filings and capital markets financing to advance its pipeline and expand geographic reach.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
246 M
Market cap (USD)
71,518
Daily traded volume (Shares)
12.7 / 11.56
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Luba Schoenig
EQUITIES OF THE SAME SECTOR
